Ensign Peak Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-146,467
| Closed | -$46.4M | – | 1770 |
|
|
2023
Q4 | $46.4M | Buy |
146,467
+5,129
| +4% | +$1.62M | 0.09% | 196 |
|
|
2023
Q3 | $23.9M | Sell |
141,338
-35,726
| -20% | -$6.04M | 0.05% | 254 |
|
|
2023
Q2 | $38.4M | Buy |
177,064
+35,749
| +25% | +$7.75M | 0.08% | 203 |
|
|
2023
Q1 | $25.7M | Hold |
141,315
| – | – | 0.06% | 254 |
|
|
2022
Q4 | $27.8M | Sell |
141,315
-34,498
| -20% | -$6.78M | 0.06% | 247 |
|
|
2022
Q3 | $39.5M | Sell |
175,813
-40,144
| -19% | -$9.03M | 0.1% | 184 |
|
|
2022
Q2 | $27.3M | Sell |
215,957
-43,004
| -17% | -$5.44M | 0.06% | 230 |
|
|
2022
Q1 | $32.8M | Buy |
258,961
+2,850
| +1% | +$361K | 0.07% | 220 |
|
|
2021
Q4 | $33.6M | Sell |
256,111
-13,408
| -5% | -$1.76M | 0.06% | 241 |
|
|
2021
Q3 | $33M | Sell |
269,519
-16,787
| -6% | -$2.05M | 0.07% | 229 |
|
|
2021
Q2 | $32.6M | Buy |
286,306
+3,313
| +1% | +$378K | 0.07% | 241 |
|
|
2021
Q1 | $34M | Buy |
282,993
+84,105
| +42% | +$10.1M | 0.07% | 226 |
|
|
2020
Q4 | $20.2M | Buy |
198,888
+26,996
| +16% | +$2.74M | 0.05% | 312 |
|
|
2020
Q3 | $13.3M | Buy |
171,892
+79,752
| +87% | +$6.17M | 0.03% | 385 |
|
|
2020
Q2 | $10.3M | Buy |
92,140
+2,947
| +3% | +$328K | 0.03% | 421 |
|
|
2020
Q1 | $6.42M | Sell |
89,193
-14,273
| -14% | -$1.03M | 0.02% | 451 |
|
|
2019
Q4 | $7.8M | Buy |
+103,466
| New | +$7.8M | 0.02% | 516 |
|